News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Optimizing Systemic Therapy in Advanced Colorectal Cancer

EP. 1: An Update on Molecular Testing in Colorectal Cancer

July 11th 2016

EP. 2: Liquid- Vs Tissue-Based Testing in Colorectal Cancer

July 11th 2016

EP. 3: Finding Actionable Biomarkers in Colorectal Cancer

July 11th 2016

EP. 4: Optimizing Care in Metastatic Colorectal Cancer

July 11th 2016

EP. 5: Multidisciplinary Approaches in Metastatic Colorectal Cancer

July 11th 2016

EP. 6: Goals of Systemic Therapy in Colorectal Cancer

July 11th 2016

EP. 7: Neoadjuvant and Adjuvant Therapy in Metastatic Colorectal Cancer

July 11th 2016

EP. 8: Colorectal Cancer: Choosing a Biologic

July 11th 2016

EP. 9: Right- Versus Left-Sided Colorectal Tumors and Survival

July 11th 2016

EP. 10: Decisions in Colorectal Cancer Maintenance Therapy and Sequencing

July 11th 2016

EP. 11: Goals of Therapy in Refractory Colorectal Cancer

July 11th 2016

EP. 12: Colorectal Cancer: Regorafenib Patient Selection and Dosing

July 11th 2016

EP. 13: Role of TAS-102 (Trifluridine/tipiracil) in Advanced Colorectal Cancer

July 11th 2016

EP. 14: Referring Patients with Colorectal Cancer to Clinical Trials

July 11th 2016

Trending on OncLive

ASCO 2026 Ushers In a New Era for Pancreatic Cancer, Expands Targeted Therapy Options Across the GI Spectrum

KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC

FDA Flashback: Breast Cancer Decisions and News From May 2026

Dr Mathews on Updated Data From the RAINFOL-01 Trial in Advanced Ovarian Cancer

Previewing Key Myeloma Presentations to Watch at EHA 2026: With Joshua Richter, MD